TP53 cancerous mutations exhibit selection for translation efficiency

Cancer Research

Volumn 69, Issue 22, 2009, Pages 8807-8813

  Waldman, Yedael Y ^a   Tuller, Tamir ^a   Sharan, Roded ^a   Ruppin, Eytan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSFER RNA;

ARTICLE; CANCER GROWTH; CHROMOSOME ABERRATION; CODON; CONTROLLED STUDY; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; RNA TRANSLATION;

ANIMALS; GENES, P53; HUMANS; MODELS, THEORETICAL; NEOPLASMS; PHYLOGENY; POINT MUTATION; PROTEIN BIOSYNTHESIS;

EID: 72249084512     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1653     Document Type: Article

References (49)

1. Sousi T, Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001;1:233-239
2. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604. (Pubitemid 37328926)
3. Russo A, Bazan V, Iacopetta B, Karr D, Sousi T, Gebbia N. The TP53 Colorectal Cancer International Collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 2005;23:7518-7528 (Pubitemid 46291815)
4. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007;26:2157-2165 (Pubitemid 46536647)
5. Levine AJ, Finlay CA, Hinds PW. p53 is a tumor suppressor gene. Cell 2004;116:S67-70.
6. Sousi T, Asselain B, Hamroun D, et al. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 2006;12:62-69 (Pubitemid 43166177)
7. Vousden KH, Prives C. p53 and prognosis: new insights and further complexity. Cell 2005;120:7-10.
8. Oren M. p53: the ultimate tumor suppressor gene? FASEB J 1992;6:169-176
9. de Vries A, Flores ER, Miranda B, et al. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc Natl Acad Sci US A 2002;99:2948-2953 (Pubitemid 34240566)
10. Wijnhoven SWP, Speksnijder EN, Liu X, et al. Dominant-negative but not gain-of-function effects of a p53.R270H mutation in mouse epithelium tissue after DNA damage. Cancer Res 2007;67:4648-4656 (Pubitemid 46910169)
11. Lee MK, Sabapathy K. The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo. J Cell Sci 2008;121: 1899-1906
12. Sigal A, Rotter V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 2000;60:6788-6793
13. Cadwell C, Zambetti GP. The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-offunction on cell growth. Gene 2001;277:15-30. (Pubitemid 32972107)
14. Olivier M, Petitjean A, Marcel V, et al. Recent advances in p53 research: an interdisciplinary perspective. Cancer Gene Ther 2009;16:1-12.
15. Glazko GV, Koonin EV, Rogozin IB. Mutation hotspots in the p53 gene in tumors of different origin: correlation with evolutionary conservation and signs of positive selection. Biochim Biophys Acta 2004;1679:95-106.
16. Duret L. tRNA gene number and codon usage in the C. elegans genome are co-adapted for optimal translation of highly expressed genes. Trends Genet 2000;16:287-289
17. Man O, Pilpel Y. Differential translation efficiency of orthologous genes is involved in phenotypic divergence of yeast species. Nat Genet 2007;39:415-421 (Pubitemid 46328488)
18. Waldman YY, Tuller T, Shlomi T, Karni S, Sharan R, Ruppin E. Gene translation efficiency in healthy and cancerous human tissues. In: Kellis M, Califano A, Stolovitzky G, editors. RECOMB Satellite on Regulatory Genomics 2008: Proceedings of the 5th Annual RECOMB Satellite on Regulatory Genomics; 2008, Oct 29- Nov 2; Cambridge, Massachusetts. Cambridge: MIT/ Broad Institute/CSAIL; 2008, p. 84.
19. Gustafsson C, Govindarajan S, Minshull J. Codon bias and heterologous protein expression. Trends Biotechnol 2004;22:346-353 (Pubitemid 38887543)
20. Chabanon H, Persson L, Wallace HM, Ferrara M, Brachet P. Increased translation efficiency and antizyme-dependent stabilization of ornithine decarboxylase in amino acid-supplemented human colon adenocarcinoma cells, Caco-2. Biochem J 2000;348:401-408
21. Jiang Y, Muschel RJ. Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. Cancer Res 2002;62: 1910-1914.
22. Audic Y, Hartley RS. Post-transcriptional regulation in cancer. Biol Cell 2004;96:479-498
23. dos Reis M, Savva R, Wernisch L. Solving the riddle of codon usage preferences: a test for translational selection. Nucleic Acids Res 2004;32:5036-5044
24. Chan PP, Lowe TM. GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Res 2009;37:D93-7.
25. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002;19:607-614
26. Ikediobi ON, Davies H, Bignell G, et al. Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. Mol Cancer Ther 2006;5:2606-2612 (Pubitemid 44848987)
27. Stern A, Doron-Faigenboim A, Erez E, Martz E, Bacharach E, Pupko T. Selecton 2007: advanced models for detecting positive and purifying selection using a Bayesian inference approach. Nucleic Acids Res 2007; 35:W506-11.
28. Durinck S, Moreau Y, Kasprzyk A, et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics 2005;21:3439-3440 (Pubitemid 41222455)
29. Graur D, Li W-H. Fundamentals of molecular evolution. 2nd ed. Sunderland: Sinauer Associates; 2000.
30. Dayhoff MO, Schwartz RM, Orcutt BC. A model of evolutionary change in proteins. Matrices for detecting distant relationships. In: Dayhoff MO, editor. Atlas of protein sequence and structure. Washington: National Biomedical Research Foundation; 1978, p. 345-358
31. Henikoff S, Henikoff JG. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci US A 1992;89:10915-10919
32. Grantham R. Amino acid difference formula to help explain protein evolution. Science 1974;185:862-864
33. Kawashima S, Ogata H, Kanehisa M. AAindex: amino acid index database. Nucleic Acids Res 1999;27: 368-369 (Pubitemid 29209488)
34. Akashi H. Translational selection and yeast proteome evolution. Genetics 2003;164:1291-1303 (Pubitemid 37102197)
35. Tuller T, Kupiec M, Ruppin E. Determinants of protein abundance and translation efficiency in S. cerevisiae. PLoS Comput Biol 2007;3:e248.
36. Sørensen MA, Pedersen S. Absolute in vivo translation rates of individual codons in Escherichia coli. The two glutamic acid codons GAA and GAG are translated with a threefold difference in rate. J Mol Biol 1991;222: 265-280 (Pubitemid 121004006)
37. Forrester K, Lupold SE, Ott VL, et al. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene 1995;10:2103-2111
38. Soussi T, Wiman KG. Shaping genetic alterations in human cancer: the p53 mutation paradigm. Cancer Cell 2007;12:302-312
39. Mertens F, Johansson B, Höglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997;57:2765-2780
40. Tsafrir D, Bacolod M, Selvanayagam Z, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006;66: 2129-2137 (Pubitemid 43294922)
41. Akashi H. Synonymous codon usage in Drosophila melanogaster: natural selection and translational accuracy. Genetics 1994;136:927-935 (Pubitemid 24085643)
42. Stoletzky N, Eyre-Walker A. Synonymous codon usage in Escherichia coli: selection for translational accuracy. Mol Biol Evol 2007;24:374-381 (Pubitemid 46204370)
43. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007;318:1382-1383
44. Ohta T, Gillespie JH. Development of neutral and nearly neutral theories. Theor Popul Biol 1996;49: 128-142
45. Bulmer M. The selection-mutation-drift theory of synonymous codon usage. Genetics 1991;129:897-907.
46. Li W-H. Models of nearly neutral mutations with particular implications for nonrandom usage of synonymous codons. J Mol Evol 1987;24:337-345
47. Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 1997;64:284-297 (Pubitemid 27355857)
48. Bamford S, Dawson E, Forbes S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 2004;91:355-358
49. In: Fritz A, Percy C, Jackm A, Shanmugaratnam K, Sobin LH, Parkin MD, editors. International classification of diseases for oncology (ICD-O). 3rd ed. Geneva: WHO; 2000.